Identification of Sox17 as a transcription factor that regulates oligodendrocyte development

Journal of Neuroscience

Volumn 26, Issue 38, 2006, Pages 9722-9735

  Sohn, Jiho ^a,c   Natale, JoAnne ^a,b,h   Chew, Li Jin ^a   Belachew, Shibeshih ^d   Cheng, Ying ^b   Aguirre, Adan ^a   Lytle, Judith ^a,e   Nait Oumesmar, Brahim ^f   Kerninon, Christophe ^f   Kanai Azuma, Masami ^g   Kanai, Yoshiakira ^g   Gallo, Vittorio ^a,b  

^a Neurosci Res Ctr Natl I   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INSERM   (France)

^g UNIVERSITY OF TOKYO   (Japan)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; Cell differentiation; Cell lineage; CNP EGFP mouse; Gene profiling; Myelin genes

Indexed keywords

MITOGENIC AGENT; MYELIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; STEM CELL; WHITE MATTER;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HMGB PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 33748906060     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1716-06.2006     Document Type: Article

References (72)

1. Aguirre A, Gallo V (2004) Postnatal neurogenesis and gliogenesis in the olfactory bulb from NG2-expressing progenitors of the subventricular zone. J Neurosci 24:10530-10541.
2. Barres BA, Lazar MA, Raff MC (1994) A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108.
3. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
4. Belachew S, Aguirre AA, Wang H, Vautier F, Yuan X, Anderson S, Kirby M, Gallo V (2002) Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. J Neurosci 22:8553-8562.
5. Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S, Gallo V (2003) Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 161:169-186.
6. Bogler O, Noble M (1994) Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division. Dev Biol 162:525-538.
7. Bogler O, Wren D, Barnett SC, Land H, Noble M (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87:6368-6372.
8. Bowles J, Schepers G, Koopman P (2000) Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227:239-255.
9. Casaccia-Bonnefil P, Liu A (2003) Relationship between cell cycle molecules and onset of oligodendrocyte differentiation. J Neurosci Res 72:1-11.
10. Casaccia-Bonnefil P, Hardy RJ, Teng KK, Levine JM, Koff A, Chao MV (1999) Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 126:4027-4037.
11. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404-6412.
12. Chittajallu R, Aguirre A, Gallo V (2004) NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J Physiol (Lond) 561:109-122.
13. +-channel regulation during oligodendrocyte development in situ. J Neurosci 25:8601-8610.
14. Di Giovanni S, Knoblach SM, Brandoli C, Aden SA, Hoffman EP, Faden AI (2003) Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol 53:454-468.
15. Fu H, Qi Y, Tan M, Cai J, Takebayashi H, Nakafuku M, Richardson W, Qiu M (2002) Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation. Development 129:681-693.
16. Gallo V, Armstrong RC (1995) Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells. J Neurosci 15:394-406.
17. + channel block. J Neurosci 16:2659-2670.
18. Ghiani C, Gallo V (2001) Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. J Neurosci 21:1274-1282.
19. Ghiani CA, Eisen AM, Yuan X, DePinho RA, McBain CJ, Gallo V (1999a) Neurotransmitter receptor activation triggers p27(Kip1)and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development 126:1077-1090.
20. + channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells. J Neurosci 19:5380-5392.
21. Gow A, Friedrich Jr VL, Lazzarini RA (1992) Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression. J Cell Biol 119:605-616.
22. Huang Z, Tang XM, Cambi F (2002) Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation. Mol Cell Neurosci 19:250-262.
23. Hudson L (2001) Control of gene expression by oligodendrocytes. In: Glial cell development (Jessen KR, Richardson WD, eds), pp 209-221. New York: Oxford UP.
24. Kan L, Israsena N, Zhang Z, Hu M, Zhao LR, Jalali A, Sahni V, Kessler JA (2004) Sox1 acts through multiple independent pathways to promote neurogenesis. Dev Biol 269:580-594.
25. Kanai Y, Kanai-Azuma M, Noce T, Saido TC, Shiroishi T, Hayashi Y, Yazaki K (1996) Identification of two Sox17 messenger RNA isoforms, with and without the high mobility group box region, and their differential expression in mouse spermatogenesis. J Cell Biol 133:667-681.
26. Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, Kurohmaru M, Sanai Y, Yonekawa H, Yazaki K, Tam PP, Hayashi Y (2002) Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129:2367-2379.
27. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD (2006) Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 9:173-179.
28. Levi G, Gallo V, Ciotti MT (1986) Bipotential precursors of putative fibrous astrocytes and oligodendrocytes in rat cerebellar cultures express distinct surface features and "neuron-like" GABA transport. Proc Natl Acad Sci USA 83:1504-1508.
29. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P (2002) Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 22:10333-10345.
30. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
31. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603-614.
32. Miller RH (2002) Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 67:451-467.
33. Montague P, Dickinson PJ, McCallion AS, Stewart GJ, Savioz A, Davies RW, Kennedy PGE, Griffiths IR (1997) Developmental expression of the murine MOBP gene. J Neurosci Res 49:133-143.
34. Natale JE, Ahmed F, Cernak I, Stoica B, Faden AI (2003) Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma 20:907-927.
35. Natale JE, Knight JB, Cheng Y, Rome JE, Gallo V (2004) Metallothionein I and II mitigate age-dependent secondary brain injury. J Neurosci Res 78:303-314.
36. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487.
37. Nielsen JA, Berndt JA, Hudson LD, Armstrong RC (2004) Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells. Mol Cell Neurosci 25:111-123.
38. Noble M (2000) Precursor cell transitions in oligodendrocyte development. J Cell Biol 148:839-842.
39. Nowakowski RS, Lewin SB, Miller MW (1989) Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J Neurocytol 18:311-318.
40. Peirano RI, Wegner M (2000) The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res 28:3047-3055.
41. Peirano RI, Goerich DE, Riethmacher D, Wegner M (2000) Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol 20:3198-3209.
42. Richardson WD, Kessaris N, Pringle N (2006) Oligodendrocyte wars. Nat Rev Neurosci 7:11-18.
43. Rogister B, Ben-Hur T, Dubois-Dalcq M (1999) From neural stem cells to myelinating oligodendrocytes. Mol Cell Neurosci 14:287-300.
44. Rowitch DH (2004) Glial specification in the vertebrate neural tube. Nat Rev Neurosci 5:409-419.
45. Sambrook J, Gething MJ (1989) Protein structure. Chaperones, paperones. Nature 342:224-225.
46. Sandberg M, Källström M, Muhr J (2005) Sox21 promotes the progression of vertebrate neurogenesis. Nat Neurosci 8:995-1001.
47. Shen S, Li J, Casaccia-Bonnefil P (2005) Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 169:577-589.
48. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522-5527.
49. Sinner D, Rankin S, Lee M, Zorn AM (2004) Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development 131:3069-3080.
50. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M (2002) Terminal differentiation of myelinforming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 16:165-170.
51. Stolt CC, Lommes P, Sock E, Chaboissier MC, Schedl A, Wegner M (2003) The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev 17:1677-1689.
52. Stolt CC, Lommes P, Friedrich RP, Wegner M (2004) Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy. Development 131:2349-2358.
53. Stolt CC, Schmitt S, Lommes P, Sock E, Wegner M (2005) Impact of transcription factor Sox8 on oligodendrocyte specification in the mouse embryonic spinal cord. Dev Biol 281:309-317.
54. Takahashi T, Nowakowski RS, Caviness Jr VS (1995) The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall. J Neurosci 15:6046-6057.
55. Takash W, Canizares J, Bonneaud N, Poulat F, Mattei MG, Jay P, Berta P (2001) SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 29:4274-4283.
56. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
57. Tokumoto YM, Durand B, Raff MC (1999) An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal. Dev Biol 213:327-339.
58. Tokumoto YM, Tang DG, Raff MC (2001) Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J 20:5261-5268.
59. Tokumoto YM, Apperly JA, Gao FB, Raff MC (2002) Posttranscriptional regulation of p18 and p27 Cdk inhibitor proteins and the timing of oligodendrocyte differentiation. Dev Biol 245:224-234.
60. Tumor Analysis Best Practices Working Group (2004) Expression profiling: best practices for data generation and interpretation in clinical trials. Nat Rev Genet 5:229-237.
61. Vallstedt A, Klos JM, Ericson J (2005) Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. Neuron 45:55-67.
62. Wegner M (2000) Transcriptional control in myelinating glia: the basic recipe. Glia 29:118-123.
63. Wegner M (2001) Expression of transcription factors during oligodendroglial development. Microsc Res Tech 52:746-752.
64. Wegner M, Stolt CC (2005) From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci 28:583-588.
65. Wolswijk G (1997) Oligodendrocyte precursor cells in chronic multiple sclerosis lesions. Mult Scler 3:168-169.
66. Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609.
67. Wolswijk G (2000) Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123:105-115.
68. Wolswijk G (2002) Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125:338-349.
69. Yuan X, Eisen AM, McBain CJ, Gallo V (1998) A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125:2901-2914.
70. Yuan X, Chittajallu R, Belachew S, Anderson S, McBain CJ, Gallo V (2002) Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. J Neurosci Res 70:529-545.
71. Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A (2001) p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2:27-34.
72. Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE (1999) Regulation of Wnt signaling by Sox proteins: XSox17 alpha/ beta and XSox3 physically interact with beta-catenin. Mol Cell 4:487-498.